Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a general funding-status notice at the top of the page. Updated the page to version 3.4.1 and removed the 3.4.0 reference.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and new metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', along with 'No FEAR Act Data' and a revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3; no user-visible changes to the Study Details page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section listing study sites in Arizona, California, Florida, Ohio, Tennessee, and Texas; updated revision to v3.3.3.SummaryDifference0.3%

- Check84 days agoChange DetectedStudy Record Dates show updated timestamps (e.g., Last Update Posted 2025-11-25 and 2025-11-10) with older entries removed. These are metadata updates and do not modify the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.